Here you can find out the latest news and announcements at Pathfinder Therapeutics, Inc. including events and product release information.
Pathfinder Therapeutics, a medical device company with first to market products for "surgical GPS" of the abdomen, is pleased to announce that it has hired Jim Cloar as President and CEO, effective immediately.
Read More... | E-mail Link
Pathfinder Therapeutics, Inc. is pleased to announce that it will be exhibiting at the annual AHPBA meeting in Miami Beach, FL from March 7 - 11, 2012.
Pathfinder is pleased to announce the sponsorship of an upcoming hepatic oncology symposium in Whistler, British Columbia, February 2-4, 2012.
In collaboration with Hitachi Aloka Medical, Ltd, Pathfinder has successfully launched Shadow, a navigated intraoperative ultrasound device for use with the image-guided liver surgery platform ExplorerTM.
Pathfinder is pleased to announce that it has finalized the acquisition of its image guided surgery platform at University of Pittsburgh Medical Center (UPMC) and the National Institute of Health (NIH).
Pathfinder Therapeutics was recently featured in an article in the Tennessee Tribune announcing the award of a $3.1 million grant from the National Cancer Institute to enhance image guided surgery techniques for safely removing liver tumors.
Pathfinder Therapeutics has finalized a clinical trial agreement with Robert Martin, M.D., at the University of Louisville Medical Center evaluating the utility of the Pathfinder technology for irreversible electroporation (IRE) procedures on the pancreas and liver.
Pathfinder Therapeutics, Inc. is pleased to announce that it will be exhibiting at the 11th annual AHPBA meeting in Miami Beach, FL from March 10 - 13, 2011.
Pathfinder Therapeutics, Inc. announced that it received FDA clearance to market its ExplorerTM – Liver Passive image-guided surgery system. ExplorerTM is indicated for use in open liver surgical procedures and consists of an optical tracking system, tracked surgical instruments, and PathwayTM, Pathfinder’s proprietary image-guided surgery software.
Pathfinder Therapeutics, Inc. has initiated a clinical study to assess the value of ExplorerTM, its image-guided surgical platform, in minimally invasive liver resections and ablations. Clinical sites participating in the study include: Memorial Sloan-Kettering Cancer Center, University of Pittsburgh Medical Center, Providence Portland Medical Center, and UNC-Chapel Hill.
Pathfinder Therapeutics, Inc. has been awarded $244,479.25 in grant funding from the IRS and Department of Health and Human Services under the Qualifying Therapeutic Discovery Project (QTDP).
Pathfinder Therapeutics, Inc., a pioneering company in the field of Navigated Abdominal Surgery (NAS), is pleased to announce that it has closed a $4 million Series B financing round co-led by TriStar Technology Fund, LLC and Limestone Fund, LLC. A number of existing investors also participated, including Hatteras Venture Partners, Florida Gulfshore Capital and Clayton Associates...
Pathfinder Therapeutics, Inc. is pleased to announce that it will be exhibiting at the 9th World Congress of the International Hepato-Pancreato-Biliary Association in Buenos Aires, Argentina from April 18 - 22, 2010.